If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
26.25    -0.25 (-0.94%)
Bid:
26.00
Ask:
26.50
Spread: 0.50 (1.923%)
Market Cap: £132.17m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Portfolio Update

13 Jan 2020 07:00

RNS Number : 5133Z
Duke Royalty Limited
13 January 2020
 

13 January 2020

 

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

 

Portfolio Update

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to update the market regarding three investments completed in December into existing portfolio companies. These investments are made in line with the Company's intended deployment of proceeds raised from the October 2019 equity issue.

 

·; Approximately £2.0 million follow-on investment into Welltel (Ireland) Limited ("Welltel"), which takes the total investment to £8.1 million. The entire facility was re-financed on Duke's typical investment terms. The proceeds were used to acquire Invistech Limited, a long established and profitable IT managed service and telecommunications business. Invistech provides strategic geographical diversification and the opportunity to cross sell to Invistech's 450 SME customer base in southern Ireland

 

·; £1.0 million follow-on investment into Trimite Global Coatings Limited ("Trimite") to support the expansion of its international operations and to conclude some legacy site rationalisation in the UK

 

·; €4.3 million follow-on investment into Temarca B.V. ("Temarca"), enabling it to acquire the only leased river cruise boat in its fleet, taking its fleet to three wholly owned vessels. A recent independent valuation conducted in November 2019 on the MS Carmen by Van Pelt and Co BV ascribed an estimated value on the vessel of €5.4 million. Duke retains a first mortgage on each of the three vessels owned by Temarca

 

Following these investments, Duke still retains approximately £31 million of additional liquidity available for new deployments, when considering existing cash resources plus the line of credit available from Honeycomb Investment Trust. This liquidity assumes a maximum of 30% loan to value in line with Duke's target maximum gearing percentage

 

 

In regard to some recent operational updates that have occurred within the Duke portfolio, Duke is pleased to announce the following highlights from some of its royalty partners:

 

·; In November 2019, Brightwater won 'Best Large Recruiter of the Year' at the 2019 National Recruitment Federation Awards in Dublin

 

·; Step Investments (via its 85% subsidiary Pearl and Dean) won back the fast-growing Everyman contract from DCM in November 2019

 

·; Welltel was a winner for the sixth consecutive year of the Deloitte "Fast-50" award in November 2019, which is an award given to the fifty fastest growing technology companies in Ireland

 

·; In December 2019, Xtremepush was awarded the Best Marketing & Services Supplier at the SBC Awards 2019 for the betting and gaming industry, held at Battersea Evolution

 

Neil Johnson, CEO of Duke, said:

 

"We enter 2020, and our last fiscal quarter, with enhanced monthly cashflows from a diversified portfolio which provides Duke shareholders with exposure to 19 underlying profitable companies. As these follow-on investments demonstrate, we are long-term partners to our companies, an approach which in turn provides Duke shareholders with the opportunity to participate in the growth of a diverse range of private companies. Helping existing Royalty Partners to acquire other businesses or hard assets enhances the underlying diversification and security of our revenue stream.

 

"We have significant means for further royalty investments to deploy against our pipeline of opportunities, and we look forward to updating the market in due course."

 

As at 31 December 2019, the portfolio breakdown was as follows:

 

Royalty Partner

Total Investment Amount

Date of Initial Investment

Temarca B.V.

€14,052,000

April 2017

Berkley Recruitment (Group) Limited

€1,300,000

June 2017

Welltel (Ireland) Limited

£8,127,000

June 2017

Lynx Equity (UK) Limited

£12,000,000

October 2017

Xtremepush Limited

£2,000,000

February 2018

Trimite Global Coatings Limited

£11,000,000

March 2018

United Glass Group Ltd

£7,500,000

April 2018

Step Investments Limited

£3,000,000

June 2018

BHPC Limited

€4,600,000

August 2018

InterHealth Canada

£10,000,000

August 2018

Brightwater Selection (Ireland) Limited

€1,875,000

September 2018

MRDB Holdings Limited Group

£10,000,000

February 2019

 

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

+44 (0) 1481 741 240

Cenkos Securities plc 

(Nominated Adviser and Broker)

Julian Morse / Michael Johnson / Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

Newgate Communications

(PR)

Elisabeth Cowell / Ian Silvera / Megan Kovach

+44 (0) 20 3757 6882

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUMZGMMLZLGGZG
Date   Source Headline
27th May 20229:08 amRNSDirector / PCA Dealings
26th May 20223:23 pmRNSResult of General Meeting and Issue of Equity
11th May 20227:05 amRNSRaises £20m through Placing and PrimaryBid Offer
10th May 20225:08 pmRNSPrimaryBid Offer
10th May 20224:44 pmRNSPlacing to raise a minimum of £15 million
28th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
20th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
11th Apr 20227:00 amRNSTrading Update
18th Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Mar 20227:00 amRNSIncreased Interim Dividend & Dividend Declaration
2nd Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
25th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Feb 20227:00 amRNSFurther re: Directorate Change
14th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
2nd Feb 20227:00 amRNSDirectorate Changes
1st Feb 202210:02 amRNSReplacement - Trading Update
1st Feb 20227:00 amRNSTrading Update
20th Jan 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
23rd Dec 20212:30 pmRNSHolding(s) in Company
23rd Dec 20217:01 amRNSTrading Update
23rd Dec 20217:00 amRNSFollow-on investment into existing Royalty Partner
22nd Dec 20213:52 pmRNSFollow-on investment into existing Royalty Partner
16th Dec 20217:00 amRNSNew Royalty Agreement
14th Dec 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
7th Dec 20217:00 amRNSEnters into Largest Royalty Agreement To Date
3rd Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSCompletion of £4.2 million Follow-On Investment
25th Nov 20217:00 amRNSNotice of Interim Results
29th Oct 20214:03 pmRNSLong Term Incentive Plan Awards
27th Oct 20217:01 amRNSFollow-On Investment into Existing Royalty Partner
27th Oct 20217:00 amRNSHolding(s) in Company
22nd Oct 20214:36 pmRNSResult of Annual General Meeting
16th Sep 20217:01 amRNSInterim Dividend and Dividend Declaration
16th Sep 20217:00 amRNSFinal Results
7th Sep 20217:00 amRNS£2.2m Follow-On Investment into Royalty Partner
2nd Sep 20217:00 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSInvestor Presentation
11th Aug 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20217:00 amRNSNotice of Results and Analyst Presentation
2nd Aug 20217:00 amRNSNew Royalty Agreement
26th Jul 20217:00 amRNSTrading Update
22nd Jul 20217:00 amRNSNew Royalty Agreement
1st Jul 20217:00 amRNSNew Royalty Agreement with Fairmed Healthcare AG
17th Jun 20217:00 amRNSInterim Dividend and Dividend Declaration
10th May 20217:00 amRNSTrading Update
20th Apr 20215:22 pmRNSHolding(s) in Company
20th Apr 20215:19 pmRNSHolding(s) in Company
20th Apr 20214:19 pmRNSHolding(s) in Company
19th Apr 202112:30 pmRNSDirector / PCA Dealings
19th Apr 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.